Cargando…

In Vitro and In Vivo Evaluation of Inhalable Ciprofloxacin Sustained Release Formulations

Respiratory antibiotics delivery has been appreciated for its high local concentration at the infection sites. Certain formulation strategies are required to improve pulmonary drug exposure and to achieve effective antimicrobial activity, especially for highly permeable antibiotics. This study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Changzhi, Guo, Kewei, Zhang, Li, Guo, Yi, Feng, Yu, Cvijić, Sandra, Cun, Dongmei, Yang, Mingshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537253/ https://www.ncbi.nlm.nih.gov/pubmed/37765256 http://dx.doi.org/10.3390/pharmaceutics15092287

Ejemplares similares

In vitro - in vivo - in silico approach in the development of inhaled drug products: Nanocrystal-based formulations with budesonide as a model drug
por: Shi, Changzhi, et al.
Publicado: (2021)

Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines
por: Guo, Yi, et al.
Publicado: (2021)

The effect of ethanol on the habit and in vitro aerodynamic results of dry powder inhalation formulations containing ciprofloxacin hydrochloride
por: Benke, Edit, et al.
Publicado: (2021)

Ciprofloxacin-Loaded Titanium Nanotubes Coated with Chitosan: A Promising Formulation with Sustained Release and Enhanced Antibacterial Properties
por: Asadi, Soada, et al.
Publicado: (2022)

Comparative in vivo bioequivalence and in vitro dissolution of two valproic acid sustained-release formulations
por: Fujii, Akira, et al.
Publicado: (2009)

Formulation and In Vitro, In Vivo Evaluation of Effervescent Floating Sustained-Release Imatinib Mesylate Tablet
por: Kadivar, Ali, et al.
Publicado: (2015)

Phages in a thermoreversible sustained-release formulation targeting E. faecalis in vitro and in vivo
por: Shlezinger, Mor, et al.
Publicado: (2019)

Development of an Inhaled Sustained Release Dry Powder Formulation of Salbutamol Sulphate, an Antiasthmatic Drug
por: Kumaresan, C., et al.
Publicado: (2016)

Inhalation of a Dry Powder Ciprofloxacin Formulation in Healthy Subjects: A Phase I Study
por: Stass, Heino, et al.
Publicado: (2013)

Correction: Formulation and In Vitro, In Vivo Evaluation of Effervescent Floating Sustained-Release Imatinib Mesylate Tablet
Publicado: (2022)

Biological Obstacles for Identifying In Vitro-In Vivo Correlations of Orally Inhaled Formulations
por: Fröhlich, Eleonore
Publicado: (2019)

Stability of Inhaled Ciprofloxacin-Loaded Poly(2-ethyl-2-oxazoline) Nanoparticle Dry Powder Inhaler Formulation in High Stressed Conditions
por: Sabuj, Mohammad Zaidur Rahman, et al.
Publicado: (2022)

Chitosan-Based Ciprofloxacin Extended Release Systems: Combined Synthetic and Pharmacological (In Vitro and In Vivo) Studies
por: Egorov, Anton R., et al.
Publicado: (2022)

Novel sustained release and swellable gastroretentive dosage form for ciprofloxacin hydrochloride
por: Gaikwad, Vinay Dhananjay, et al.
Publicado: (2014)

Formulation of Lipid-Based Tableted Spray-Congealed Microparticles for Sustained Release of Vildagliptin: In Vitro and In Vivo Studies
por: Al Zahabi, Khaled H., et al.
Publicado: (2021)

Comparative Assessment of In Vitro and In Silico Methods for Aerodynamic Characterization of Powders for Inhalation
por: Ignjatović, Jelisaveta, et al.
Publicado: (2021)

Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)

Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach
por: Karimi, Keyhaneh, et al.
Publicado: (2016)

In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis
por: Tagalakis, Aristides D., et al.
Publicado: (2018)

Preparation, Characterization and in vivo Evaluation of Parenteral Sustained Release Microsphere Formulation of Zopiclone
por: Swapna, N, et al.
Publicado: (2010)

An in vivo pharmacokinetic study of metformin microparticles as an oral sustained release formulation in rabbits
por: Bouriche, Sihem, et al.
Publicado: (2021)

In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates
por: Liu, Yanyan, et al.
Publicado: (2019)

Inhaled ciprofloxacin-loaded poly(2-ethyl-2-oxazoline) nanoparticles from dry powder inhaler formulation for the potential treatment of lower respiratory tract infections
por: Sabuj, Mohammad Zaidur Rahman, et al.
Publicado: (2021)

Preparation of 5-fluorouracil-loaded chitosan nanoparticles and study of the sustained release in vitro and in vivo
por: Sun, Li, et al.
Publicado: (2017)

In Vitro Drug Release, Permeability, and Structural Test of Ciprofloxacin-Loaded Nanofibers
por: Uhljar, Luca Éva, et al.
Publicado: (2021)

Levonorgestrel Microneedle Array Patch for Sustained Release Contraception: Formulation, Optimization and In Vivo Characterization
por: Rajput, Amarjitsing, et al.
Publicado: (2022)

Development of In Vitro–In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation
por: Mohamed, Mohamed-Eslam F., et al.
Publicado: (2019)

Formulation and evaluation of controlled-release of telmisartan microspheres: In vitro/in vivo study
por: Gaur, Praveen Kumar, et al.
Publicado: (2014)

Preparation, optimization and in vitro–in vivo evaluation of Shunxin sustained release granules
por: Dou, Yinghuan, et al.
Publicado: (2019)

Cubic phase nanoparticles for sustained release of ibuprofen: formulation, characterization, and enhanced bioavailability study
por: Dian, Linghui, et al.
Publicado: (2013)

Co-delivery of resveratrol and docetaxel via polymeric micelles to improve the treatment of drug-resistant tumors()
por: Guo, Xiong, et al.
Publicado: (2019)

OTO-201: Nonclinical Assessment of a Sustained-Release Ciprofloxacin Hydrogel for the Treatment of Otitis Media
por: Wang, Xiaobo, et al.
Publicado: (2014)

Comparison of Phospholipid-Based Particles for Sustained Release of Ciprofloxacin Following Pulmonary Administration to Bronchiectasis Patients
por: Weers, Jeffry
Publicado: (2019)

Enhanced NSAIDs Solubility in Drug–Drug Formulations with Ciprofloxacin †
por: Acebedo-Martínez, Francisco Javier, et al.
Publicado: (2023)

Ionic Cross-linked Chitosan Beads for Extended Release of Ciprofloxacin: In vitro Characterization
por: Srinatha, A., et al.
Publicado: (2008)

Formulation and In vitro Evaluation of Sustained Release Dosage Form with Taste Masking of Metformin Hydrochloride
por: Bhoyar, P. K., et al.
Publicado: (2010)

Numerical Modeling of Particle Dynamics Inside a Dry Powder Inhaler
por: Šušteršič, Tijana, et al.
Publicado: (2022)

Aerosol Performance and Long-Term Stability of Surfactant-Associated Liposomal Ciprofloxacin Formulations with Modified Encapsulation and Release Properties
por: Cipolla, David, et al.
Publicado: (2014)

In-vitro and in-vivo respiratory deposition of a developed metered dose inhaler formulation of an anti-migraine drug
por: Abdou, Ebtsam M., et al.
Publicado: (2019)

Formulation development, in vivo bioequivalence and pediatric PBPK modeling studies of taste-masked ciprofloxacin chewable tablets
por: Usmani, Muhammad Talha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p7ametagmhdin5lj4loagk6hsf